Targeted degradation of ⍺-synuclein aggregates in Parkinson’s disease using the AUTOTAC technology

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource, 1 online resource.
Language
Englisch

Bibliographic citation
Targeted degradation of ⍺-synuclein aggregates in Parkinson’s disease using the AUTOTAC technology ; volume:18 ; number:1 ; day:24 ; month:6 ; year:2023 ; pages:1-21 ; date:12.2023
Molecular neurodegeneration ; 18, Heft 1 (24.6.2023), 1-21, 12.2023

Creator
Lee, Jihoon
Sung, Ki Woon
Bae, Eun-Jin
Yoon, Dabin
Kim, Dasarang
Lee, Jin Saem
Park, Da-ha
Park, Daniel Youngjae
Mun, Su Ran
Kwon, Soon Chul
Kim, Hye Yeon
Min, Joo-Ok
Lee, Seung-Jae
Suh, Young Ho
Kwon, Yong Tae
Contributor
SpringerLink (Online service)

DOI
10.1186/s13024-023-00630-7
URN
urn:nbn:de:101:1-2023092610563343207976
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:50 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Lee, Jihoon
  • Sung, Ki Woon
  • Bae, Eun-Jin
  • Yoon, Dabin
  • Kim, Dasarang
  • Lee, Jin Saem
  • Park, Da-ha
  • Park, Daniel Youngjae
  • Mun, Su Ran
  • Kwon, Soon Chul
  • Kim, Hye Yeon
  • Min, Joo-Ok
  • Lee, Seung-Jae
  • Suh, Young Ho
  • Kwon, Yong Tae
  • SpringerLink (Online service)

Other Objects (12)

Correction: Targeted degradation of ⍺-synuclein aggregates in Parkinson’s disease using the AUTOTAC technology

Correction: Targeted degradation of ⍺-synuclein aggregates in Parkinson’s disease using the AUTOTAC technology

Dermal α-synuclein oligomers and aggregates in Parkinson’s disease

Dermal α-synuclein oligomers and aggregates in Parkinson’s disease

Small soluble α-synuclein aggregates are the toxic species in Parkinson’s disease

Small soluble α-synuclein aggregates are the toxic species in Parkinson’s disease

Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson’s disease patients

Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson’s disease patients

Mitochondria-targeted oligomeric α-synuclein induces TOM40 degradation and mitochondrial dysfunction in Parkinson’s disease and parkinsonism-dementia of Guam

Mitochondria-targeted oligomeric α-synuclein induces TOM40 degradation and mitochondrial dysfunction in Parkinson’s disease and parkinsonism-dementia of Guam

Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease

Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease

Transmission of alpha-synuclein in Parkinson’s disease

Transmission of alpha-synuclein in Parkinson’s disease

Oligomerization, Degradation and Aggregation Reactions and Products of Synuclein Polypeptides Related to Parkinson’s Disease

Hochschulschrift

Oligomerization, Degradation and Aggregation Reactions and Products of Synuclein Polypeptides Related to Parkinson’s Disease

Correction: Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease

Correction: Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease

Models of α-synuclein aggregation in Parkinson’s disease

Models of α-synuclein aggregation in Parkinson’s disease

Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson’s disease model

Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson’s disease model

Novel targeted therapies for Parkinson’s disease

Novel targeted therapies for Parkinson’s disease

Related objects